ARTICLE | Company News
Amgen, Amsterdam Molecular deal
December 6, 2010 8:00 AM UTC
The partners added rights for all gene therapy indications to their 2008 deal granting Amsterdam Molecular exclusive, worldwide rights to Amgen's glial derived neurotrophic factor (GDNF) gene. Amsterd...